> A group of university investigators say that they used a gene therapy to replace retGC1 and fully restored visual function in a mouse model for Leber congenital amaurosis-1 (LCA1) that persisted for at least 6 months. Release
> Scientists at the University of Chicago Medical Center say they were able to control the activity of enzymes through the use of "synthetic, antibody-like proteins known as monobodies." Release